in Nature Nanotechnology in 2017, discovered a synthetic nanoparticle named PC7A that enhances antigen delivery and cross-presentation, stimulating the STING pathway to boost antitumor immunity for cancer immunotherapy (37). Here, STING1 is linked to cancer.